Glucose oxidase-encapsulated liposomes for amplified autofluorescence-free immunoassay of a prostate-specific antigen with photoluminescence of CePO:Tb nanocrystals
Lanthanide-doped inorganic nanocrystals have attracted extensive attention due to their long luminescence lifetime and large Stokes shift. In this work, an immunosensing platform based on CePO 4 :Tb (CPOT) was successfully constructed, which could avoid the autofluorescence interference of complex b...
Saved in:
Published in | Analyst (London) Vol. 147; no. 24; pp. 568 - 5686 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Published |
05.12.2022
|
Online Access | Get full text |
Cover
Loading…
Summary: | Lanthanide-doped inorganic nanocrystals have attracted extensive attention due to their long luminescence lifetime and large Stokes shift. In this work, an immunosensing platform based on CePO
4
:Tb (CPOT) was successfully constructed, which could avoid the autofluorescence interference of complex biological matrices. Specifically, CPOT was synthesized by a solvothermal method, which exhibited H
2
O
2
-responsive luminescence behavior. Taking advantage of this feature, an autofluorescence-free immunosensor with CPOT as the probe and H
2
O
2
as the quencher was developed to detect prostate-specific antigen (PSA). Functionalized liposomes were used to encapsulate glucose oxidase (GOD) and labeled on detection antibodies to improve the sensitivity of the probe. Under the proven optimal experimental conditions, the developed autofluorescence-free immunosensor exhibited a linear luminescence response to the logarithm of PSA concentration (0.005-25 ng mL
−1
) with a limit of detection (LOD) of 3.25 pg mL
−1
. The performance shows that the autofluorescence-free immunosensor based on this strategy opens up a new field of vision for clinical PSA detection.
An autofluorescence-free immunosensing platform was designed to determine prostate-specific antigen based on the photoluminescence of CePO
4
:Tb nanocrystals. |
---|---|
Bibliography: | Electronic supplementary information (ESI) available. See DOI https://doi.org/10.1039/d2an01689c |
ISSN: | 0003-2654 1364-5528 |
DOI: | 10.1039/d2an01689c |